Restart Life Sciences Signs Binding LOI to Acquire The Holy Crap Foods Portfolio of Brands and Manufacturing Plant 
Kinnate Biopharma Announces Pricing of Initial Public Offering
SAN FRANCISCO and SAN DIEGO, Dec. 02, 2020 (GLOBE NEWSWIRE) -- Kinnate Biopharma Inc. (Nasdaq: KNTE) (“Kinnate”), a biopharmaceutical company focused...
Codexis Announces Pricing of Public Offering of Common Stock
REDWOOD CITY, Calif., Dec. 02, 2020 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq:CDXS), a leading protein engineering company, today announced the...
Mersana Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
CAMBRIDGE, Mass., Dec. 02, 2020 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (Nasdaq: MRSN), a clinical-stage biopharmaceutical company focused on discovering...
Codexis Announces Proposed Public Offering of Common Stock
REDWOOD CITY, Calif., Dec. 02, 2020 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq:CDXS), a leading protein engineering company, today announced that...
Avid Bioservices Reports Financial Results for Second Quarter Fiscal 2021 and Recent Developments
-- Recorded Second Quarter Revenue of $21.1 Million -- -- Signed $28 Million in Business Orders and Ended the Quarter...
Stryker declares a $0.63 per share quarterly dividend
Kalamazoo, Michigan, Dec. 02, 2020 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly...
BETTERLIFE PHARMA ANNOUNCES CLOSING OF $2.9 MILLION PRIVATE PLACEMENT OFFERING
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR...
SeaSpine Announces Limited Commercial Launch of its Admiral™ ACP System
CARLSBAD, Calif., Dec. 02, 2020 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical...
Arcutis to Host Virtual Investor Day on Wednesday, December 9, 2020
WESTLAKE VILLAGE, Calif., Dec. 02, 2020 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on...
Epidemiologist Dr. Joel Moody Joins Revive Therapeutics as Medical and Clinical Advisor
TORONTO, Dec. 02, 2020 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive”) (CSE: RVV, USA: RVVTF), a specialty life sciences company...
Chembio Diagnostics Awarded $12.7 Million by BARDA for Development of Rapid DPP Respiratory Antigen Panel and 510(k) Submission of the Rapid DPP SARS-CoV-2 Antigen Test System
HAUPPAUGE, N.Y., Dec. 02, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI) a leading point-of-care diagnostic company focused on infectious...
Recording of the Third Quarter 2020 Investor Conference Webinar
On December 2, 2020 JSC Olainfarm organized its Investor Conference Online Webinar. During the webinar members of the management board...
MEDITECH Selects Google Cloud to Power EHR Solutions
EHR vendor to offer cloud based solutions via subscription model, delivered on Google Cloud WESTWOOD, Mass.--(BUSINESS WIRE)--Today MEDITECH introduced MEDITECH...
McKesson Ventures Invests as Clinical Ink Debuts Lunexis™ ePRO+ Solution
Mixed Modalities Allow Users to Switch Between Smartphones, Tablets, and Web Any Time HORSHAM, Pa.--(BUSINESS WIRE)--Clinical Ink, a global clinical...
McKesson Launches Ontada, an Oncology Technology and Insights Business Dedicated to Help Advance Cancer Research and Care
IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation today announced the launch of Ontada, an oncology technology and insights business designed to support innovation,...
New study: Only reliable rapid corona tests make sense
More and more manufacturers are bringing corona rapid tests onto the market. But only if they provide reliable results does...
VIVIS Hires National Sales Team as New CBD Pain Cream Nears Launch Date
KATY, TX / ACCESSWIRE / December 3, 2020 / Neutra Corporation (OTC PINK:NTRR) subsidiary VIVIS is ramping up efforts to enter...
Outset Medical Announces Pricing of Secondary Public Offering
SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the...
DGAP-News: MorphoSys’ Licensee Announces Approval by the European Commission for Tremfya(R) (guselkumab) for Treatment of Adults with Active Psoriatic Arthritis (PsA)
PLANEGG, MUNICH, GERMANY / ACCESSWIRE / December 2, 2020 / MorphoSys AG (FSE:MOR; Prime Standard Segment; MDAX & TecDAX; NASDAQ:MOR)...
Core One Labs Announces Resumption of Trading
VANCOUVER, BC / ACCESSWIRE / December 2, 2020 / Core One Labs Inc. (CSE:COOL)(OTCQX:CLABF)(FSE:LD62)(WKN:A14XHT) (the "Company") is pleased to announce...